• FOLLOW US
Video Player
  • Email
  • share

Cost cutting boosts Merck's profit

Merck offset patent expirations on drugs by drastically slashing R&D costs. It's in talks to sell its consumer unit to Reckitt Benckiser. Fred Katayama reports.

http://www.wkyc.com/video/3520246237001/53403670001/Cost-cutting-boosts-Mercks-profit http://cdn.newslook.com/8c/8c9ab7bf8e86e3ae74e08ecbb35d455b/images/frame_ext.jpg Cost cutting boosts Merck's profit Merck offset patent expirations on drugs by drastically slashing R&D costs. It's in talks to sell its consumer unit to Reckitt Benckiser. Fred Katayama reports. FinanceReutersHealthValeantastrazeneca plcmerckpfizerUnited KingdomallerganReckitt BenckiserAZNnewslookFred KatayamaWorldGermany 01:27

More Videos